69 years old male patient, with impairment of physical condition, hyperpigmentation, cutaneos lesion and a deficient response to treatment

被引:0
作者
De Paula, J. M. Prieto [1 ]
Montilla, M. A. Aliaga Y. [1 ]
Fernandez, J. I. Alonso [1 ]
Serradilla, J. I. Martin [1 ]
Sarabia, A. Relea [2 ]
Nicas, V. Villamandos [3 ]
机构
[1] Complejo Hosp Palencia, Med Interna Serv, Burgos, Spain
[2] Complejo Hosp Palencia, Serv Radiodiagnost, Burgos, Spain
[3] Hosp Aranda, Serv Analisis, Burgos, Spain
关键词
adrenal insufficiency primary; cutaneous tuberculosis; adrenal tuberculosis; rifampicin; addisonian crisis;
D O I
暂无
中图分类号
学科分类号
摘要
We submit the case of a male patient, suffering from a tuberculous ethiology adrenal primary insufficiency, showing a dermal lesion, in which necrotizing granulomas were found, and from which bacterial culture growth yielded mycobacterium bovis. Given the clinical findings, and awaiting for the bacterial culture result, a triple treatment with tuberculostatics was started, but had to be discontinued because of hepatic toxicity. After culture of cutaneous biopsy yielded micobaterium tuberculosis, treatment with streptomycin, rifampicin and etambutol was restarted. Three weeks later, in spite of increasing hydrocortisone dose to 40 mg, adrenal insufficiency reappeared. Under the circumstances, we chose to continue rifampicin and double hydrocortisone dose. The case is of concern because of the concurrency of three nowadays infrequent disorders: tuberculous ethiology adrenal insufficiency, cutaneous tuberculosis due to mycobacterium bovis and primary adrenal insufficiency due to rifampicin treatment, the latter resolved after increasing hydrocortisone dose.
引用
收藏
页码:599 / 601
页数:3
相关论文
共 11 条
  • [1] ALONSO N, 2003, ENDOCRINOL NUTR, V50, P390
  • [2] Development of a polymerase chain reaction dot-blotting system for detecting cutaneous tuberculosis
    Arora, SK
    Kumar, B
    Sehgal, S
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2000, 142 (01) : 72 - 76
  • [3] BACARIZO P, 2006, ENDOCRINOL NUTR, V53, P510
  • [4] Carapeto FJ, 2004, PIEL, V19, P63
  • [5] Drugs with activity against Mycobacterium tuberculosis
    Coll, P
    [J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2003, 21 (06): : 299 - 308
  • [6] ABNORMAL OVERNIGHT DEXAMETHASONE SUPPRESSION TEST IN SUBJECTS RECEIVING RIFAMPICIN THERAPY
    KYRIAZOPOULOU, V
    VAGENAKIS, AG
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1992, 75 (01) : 315 - 317
  • [7] Lorente R, 1997, REV CLIN ESP, V197, P725
  • [8] LUCERGA BB, 2004, MED INTERNA, P2492
  • [9] RABINOVICH IH, 1993, MED CLIN-BARCELONA, V101, P132
  • [10] Rincon JMR, 1996, REV CLIN ESP, V196, P39